Form 8-K - Current report:
SEC Accession No. 0001520138-25-000223
Filing Date
2025-07-23
Accepted
2025-07-23 16:49:55
Documents
14
Period of Report
2025-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT bivi-20250722_8k.htm   iXBRL 8-K 27404
2 EXHIBIT 99.1 bivi-20250722_8kex99z1.htm EX-99.1 10518
6 GRAPHIC image_001.jpg GRAPHIC 26245
  Complete submission text file 0001520138-25-000223.txt   243558

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20250718.xsd EX-101.SCH 3026
4 XBRL LABEL FILE bivi-20250718_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE bivi-20250718_pre.xml EX-101.PRE 22366
16 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20250722_8k_htm.xml XML 3568
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 251143658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)